RT @FrontOncology: New research: Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab,…
7,381 followers
6,549 followers
New research: Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis: Background: The use of… https://t.co/hBCNxno
405 followers
RT @abdulaali2011: Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, an…
260 followers
RT @abdulaali2011: Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, an…